Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
Qian Tang, Hu Ouyang, Dongxiu He, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 2800-2809
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice
Laura López-González, Alicia Sánchez Cendra, Cristina Sánchez Cendra, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 168-168
Open Access | Times Cited: 17
Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
Xiang Song, Xinzhao Wang, Zhaoyun Liu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 122
Epigenetic Alterations in Triple-Negative Breast Cancer—The Critical Role of Extracellular Matrix
Vasiliki Zolota, Vassiliki Tzelepi, Zoi Piperigkou, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 713-713
Open Access | Times Cited: 58
MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68
Triple negative breast cancer in the era of miRNA
Hussein Sabit, Emre Çevik, Hüseyin Tombuloğlu, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103196-103196
Closed Access | Times Cited: 53
MiR-21 Is Required for the Epithelial–Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells
Elif Damla Arısan, Özge Rencüzoğulları, Clara Cieza-Borrella, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1557-1557
Open Access | Times Cited: 48
MitomiRs: their roles in mitochondria and importance in cancer cell metabolism
Andrej Renčelj, Nada Gvozdenovic, Maja Čemažar
Radiology and Oncology (2021) Vol. 55, Iss. 4, pp. 379-392
Open Access | Times Cited: 43
High electrochemical active Au-NP/2D zinc-metal organic frameworks heterostructure-based ECL sensor for the miRNA-522 detection in triple negative breast cancer
Weiyao Zhong, Yang Zhang, He Zhao, et al.
Talanta (2023) Vol. 265, pp. 124875-124875
Closed Access | Times Cited: 19
Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression
Fu Peng, Li Wang, Liang Xiong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Single-Molecule Sensor for High-Confidence Detection of miRNA
Kalani M. Wijesinghe, Mazhar A. Kanak, J. Chuck Harrell, et al.
ACS Sensors (2022) Vol. 7, Iss. 4, pp. 1086-1094
Open Access | Times Cited: 20
Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology
Asadoor Amirkhani Namagerdi, Danila d’Angelo, Francesca Ciani, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 28
Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis
Amal Qattan, Taher Al‐Tweigeri, Wafa Alkhayal, et al.
Genes (2021) Vol. 12, Iss. 4, pp. 549-549
Open Access | Times Cited: 24
Gold Nanorod Vertical Array-Based Electrochemiluminescence Polarization Assay for Triple-Negative Breast Cancer Detection
Zihui Liang, Junyi Zhao, Peilin Wang, et al.
Analytical Chemistry (2021) Vol. 94, Iss. 2, pp. 1221-1229
Closed Access | Times Cited: 24
Functional mechanisms of miR‐192 family in cancer
Mohammad Amir Mishan, Mohammad Amin Khazeei Tabari, Javad Parnian, et al.
Genes Chromosomes and Cancer (2020) Vol. 59, Iss. 12, pp. 722-735
Closed Access | Times Cited: 25
Circulating microRNAs and their role in the immune response in triple‑negative breast cancer (Review)
Patricia Piña‐Sánchez, Hilda-Alicia Valdez‐Salazar, Martha-Eugenia Ruiz‐Tachiquín
Oncology Letters (2020) Vol. 20, Iss. 5, pp. 1-1
Open Access | Times Cited: 18
Melatonin and Regulation of miRNAs: Novel Targeted Therapy for Cancerous and Noncancerous Disease
Mohammad Hossein Pourhanifeh, Saeed Mehrzadi, Azam Hosseinzadeh
Epigenomics (2020) Vol. 13, Iss. 1, pp. 65-81
Closed Access | Times Cited: 18
A polarization-resolved ECL strategy based on the surface plasmon coupling effect of orientational Au nanobipyramids patterned structures
Peilin Wang, Zihui Liang, Junyi Zhao, et al.
Chemical Engineering Journal (2022) Vol. 448, pp. 137630-137630
Closed Access | Times Cited: 11
MicroRNA-105 plays an independent prognostic role in esophageal cancer and acts as an oncogene
Ruixiang Gao, Zhen Wang, Qiang Liu, et al.
Cancer Biomarkers (2019), pp. 1-8
Closed Access | Times Cited: 16
Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
Lisa Linck, Claus Hellerbrand, Anja‐Katrin Bosserhoff, et al.
Cells (2020) Vol. 9, Iss. 1, pp. 114-114
Open Access | Times Cited: 15
Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets
Ishita Gupta, Balsam Rizeq, Semir Vranić, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6750-6750
Open Access | Times Cited: 15
MicroRNA-105 plays an independent prognostic role in esophageal cancer and acts as an oncogene
Ruixiang Gao, Zhen Wang, Qiang Liu, et al.
Cancer Biomarkers (2019) Vol. 27, Iss. 2, pp. 173-180
Closed Access | Times Cited: 14
Functionalized PAMAM-Based system for targeted delivery of miR-205 and 5-fluorouracil in breast cancer
Qian Tang, Daquan Liu, Hong‐Yuan Chen, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 67, pp. 102959-102959
Closed Access | Times Cited: 12
Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer
Acharya Balkrishna, Rashmi Mittal, Vedpriya Arya
Current Cancer Drug Targets (2020) Vol. 21, Iss. 2, pp. 153-162
Closed Access | Times Cited: 10
A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer
Safaa Turkistani, Bruna M. Sugita, Paolo Fadda, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Highly connected, non-redundant microRNA functional control in breast cancer molecular subtypes
Guillermo de Anda‐Jáuregui, Jesús Espinal‐Enríquez, Enrique Hernández-Lemus
Interface Focus (2021) Vol. 11, Iss. 4, pp. 20200073-20200073
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top